Stocks and Investing Stocks and Investing
Fri, October 20, 2017

Douglas Tsao Maintained (TEVA) at Hold with Decreased Target to $19 on, Oct 20th, 2017


Published on 2024-10-25 23:44:14 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $21 to $19 on, Oct 20th, 2017.

Douglas has made no other calls on TEVA in the last 4 months.



There are 8 other peers that have a rating on TEVA. Out of the 8 peers that are also analyzing TEVA, 4 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017


These are the ratings of the 4 analyists that currently disagree with Douglas


  • David Risinger of "Morgan Stanley" Maintained at Sell with Decreased Target to $15 on, Thursday, October 5th, 2017
  • Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
  • Vamil Divan of "JMP Securities" Maintained at Sell with Increased Target to $14 on, Wednesday, September 6th, 2017
  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017
Contributing Sources